Home  »  Industry   »  Boiling and ready to burst as BioCryst Pharmaceuti...

Boiling and ready to burst as BioCryst Pharmaceuticals Inc. (BCRX) last month performance was 0.09%

At the end of the latest market close, BioCryst Pharmaceuticals Inc. (BCRX) was valued at $11.12. In that particular session, Stock kicked-off at the price of $11.29 while reaching the peak value of $11.7492 and lowest value recorded on the day was $11.02. The stock current value is $11.15.Recently in News on July 21, 2022, BioCryst to Report Second Quarter 2022 Financial Results on August 4. BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company will report its second quarter 2022 financial results Thursday, August 4, 2022. You can read further details here

BioCryst Pharmaceuticals Inc. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $19.99 on 02/16/22, with the lowest value was $7.61 for the same time period, recorded on 05/12/22.

Top 5 Cheap Stocks to Own Right Now

While finding safe stocks with the potential for monster gains isn't always easy, we've found a few that could pay out well. In fact, within our report, "Top 5 Cheap Stock to Own Right Now", we have identified five stocks we believe could appreciate the most even if you just have $1,000 to invest.

Sign up here to get your free report now. .


BioCryst Pharmaceuticals Inc. (BCRX) full year performance was -33.47%

Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, BioCryst Pharmaceuticals Inc. shares are logging -44.22% during the 52-week period from high price, and 46.52% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $7.61 and $19.99.

The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 3168795 for the day, which was evidently lower, when compared to the average daily volumes of the shares.

When it comes to the year-to-date metrics, the BioCryst Pharmaceuticals Inc. (BCRX) recorded performance in the market was -19.49%, having the revenues showcasing 13.78% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 2.08B, as it employees total of 358 workers.

Specialists analysis on BioCryst Pharmaceuticals Inc. (BCRX)

During the last month, 0 analysts gave the BioCryst Pharmaceuticals Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.

According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 11.42, with a change in the price was noted -5.69. In a similar fashion, BioCryst Pharmaceuticals Inc. posted a movement of -33.79% for the period of last 100 days, recording 4,098,758 in trading volumes.

Trends and Technical analysis: BioCryst Pharmaceuticals Inc. (BCRX)

Raw Stochastic average of BioCryst Pharmaceuticals Inc. in the period of last 50 days is set at 69.50%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 33.24%. In the last 20 days, the company’s Stochastic %K was 27.01% and its Stochastic %D was recorded 27.48%.

Now, considering the stocks previous presentation, multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -19.49%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -27.27%, alongside a downfall of -33.47% for the period of the last 12 months. The shares increased approximately by 0.90% in the 7-day charts and went up by 0.09% in the period of the last 30 days. Common stock shares were driven by 13.78% during last recorded quarter.

Leave a Comment

Your email address will not be published.

On Key

Related Posts